首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >In utero management of fetal lower urinary tract obstruction with a novel shunt: a landmark development in fetal therapy.
【24h】

In utero management of fetal lower urinary tract obstruction with a novel shunt: a landmark development in fetal therapy.

机译:在子宫内用新型分流管治疗胎儿下尿路梗阻:胎儿治疗的一个里程碑式的发展。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Fetal lower urinary tract obstruction occurs in approximately 1:3000 pregnancies. Standard vesicoamniotic shunting is fraught with malfunctioning in upto 60% of cases. We hereby report the development and application of a novel and reliable shunt. MATERIALS AND METHODS: Patients with lower urinary tract obstruction were offered the novel shunt among other standard management options. Shunting involved the placement of a double disk device with a standard double pig-tail catheter. All patients signed informed consent. RESULTS: Four patients have been treated with the novel shunt. In three patients, shunting was conducted between the bladder and amniotic cavity. In one patient (dichorionic-discordant twins) with a prior dislodged shunt causing urinary ascites, shunting was conducted between the peritoneal and amniotic cavities ('bridge shunt'). In all cases, correct and stable shunt placement was confirmed endoscopically and sonographically and in all patients, the fetal bladder remains effectively drained. CONCLUSION: Reliable and effective vesico or peritoneoamniotic shunting can be achieved with the novel shunt. This shunt cannot become dislodged into the peritoneal cavity or the amniotic cavity, and cannot be pulled out by the fetus. Further experience is necessary to determine the risks and benefits of this novel treatment for fetal lower urinary tract obstruction.
机译:目的:胎儿下尿路梗阻发生在大约1:3000的妊娠中。在多达60%的病例中,标准的羊水囊肿分流器充满了故障。我们特此报告新型可靠分流器的开发和应用。材料与方法:在其他标准治疗方案中,为下尿路梗阻患者提供了新型分流器。分流包括放置带有标准双尾纤导管的双盘器械。所有患者签署知情同意书。结果:四例患者接受了新型分流器的治疗。在三例患者中,在膀胱和羊膜腔之间进行了分流。在一名先前因尿路腹水移位而分流的患者(二甲胎双顺位双胞胎)中,在腹膜腔和羊膜腔之间进行了分流(“桥式分流”)。在所有情况下,均通过内镜和超声检查确认正确,稳定的分流放置,并且在所有患者中,胎儿膀胱均保持有效引流。结论:新型分流器可实现可靠有效的膀胱或腹膜羊膜分流。该分流器不能移入腹膜腔或羊膜腔,也不能被胎儿拉出。为了确定这种新疗法对胎儿下尿路梗阻的风险和益处,还需要进一步的经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号